Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
bioRxiv ; 2023 Mar 24.
Article in English | MEDLINE | ID: mdl-36993380

ABSTRACT

The condition of having a healthy, functional proteome is known as protein homeostasis, or proteostasis. Establishing and maintaining proteostasis is the province of the proteostasis network, approximately 2,700 components that regulate protein synthesis, folding, localization, and degradation. The proteostasis network is a fundamental entity in biology that is essential for cellular health and has direct relevance to many diseases of protein conformation. However, it is not well defined or annotated, which hinders its functional characterization in health and disease. In this series of manuscripts, we aim to operationally define the human proteostasis network by providing a comprehensive, annotated list of its components. We provided in a previous manuscript a list of chaperones and folding enzymes as well as the components that make up the machineries for protein synthesis, protein trafficking into and out of organelles, and organelle-specific degradation pathways. Here, we provide a curated list of 838 unique high-confidence components of the autophagy-lysosome pathway, one of the two major protein degradation systems in human cells.

2.
Nature ; 601(7894): 637-642, 2022 01.
Article in English | MEDLINE | ID: mdl-35046576

ABSTRACT

Ageing is accompanied by a decline in cellular proteostasis, which underlies many age-related protein misfolding diseases1,2. Yet, how ageing impairs proteostasis remains unclear. As nascent polypeptides represent a substantial burden on the proteostasis network3, we hypothesized that altered translational efficiency during ageing could help to drive the collapse of proteostasis. Here we show that ageing alters the kinetics of translation elongation in both Caenorhabditis elegans and Saccharomyces cerevisiae. Ribosome pausing was exacerbated at specific positions in aged yeast and worms, including polybasic stretches, leading to increased ribosome collisions known to trigger ribosome-associated quality control (RQC)4-6. Notably, aged yeast cells exhibited impaired clearance and increased aggregation of RQC substrates, indicating that ageing overwhelms this pathway. Indeed, long-lived yeast mutants reduced age-dependent ribosome pausing, and extended lifespan correlated with greater flux through the RQC pathway. Further linking altered translation to proteostasis collapse, we found that nascent polypeptides exhibiting age-dependent ribosome pausing in C. elegans were strongly enriched among age-dependent protein aggregates. Notably, ageing increased the pausing and aggregation of many components of proteostasis, which could initiate a cycle of proteostasis collapse. We propose that increased ribosome pausing, leading to RQC overload and nascent polypeptide aggregation, critically contributes to proteostasis impairment and systemic decline during ageing.


Subject(s)
Proteostasis , Saccharomyces cerevisiae Proteins , Aging , Animals , Caenorhabditis elegans/metabolism , Peptides/metabolism , Protein Biosynthesis , Ribosomes/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/metabolism , Ubiquitin-Protein Ligases/metabolism
3.
Mol Cell ; 78(2): 329-345.e9, 2020 04 16.
Article in English | MEDLINE | ID: mdl-32268122

ABSTRACT

Neural stem and progenitor cells (NSPCs) are critical for continued cellular replacement in the adult brain. Lifelong maintenance of a functional NSPC pool necessitates stringent mechanisms to preserve a pristine proteome. We find that the NSPC chaperone network robustly maintains misfolded protein solubility and stress resilience through high levels of the ATP-dependent chaperonin TRiC/CCT. Strikingly, NSPC differentiation rewires the cellular chaperone network, reducing TRiC/CCT levels and inducing those of the ATP-independent small heat shock proteins (sHSPs). This switches the proteostasis strategy in neural progeny cells to promote sequestration of misfolded proteins into protective inclusions. The chaperone network of NSPCs is more effective than that of differentiated cells, leading to improved management of proteotoxic stress and amyloidogenic proteins. However, NSPC proteostasis is impaired by brain aging. The less efficient chaperone network of differentiated neural progeny may contribute to their enhanced susceptibility to neurodegenerative diseases characterized by aberrant protein misfolding and aggregation.


Subject(s)
Aging/genetics , Molecular Chaperones/genetics , Neural Stem Cells/metabolism , Protein Aggregation, Pathological/genetics , Adenosine Triphosphate/genetics , Aging/pathology , Animals , Brain/growth & development , Brain/pathology , Cell Differentiation/genetics , Chaperonins/genetics , Gene Expression Regulation, Developmental/genetics , Gene Regulatory Networks/genetics , Mice , Molecular Chaperones/metabolism , Neural Stem Cells/pathology , Protein Folding , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Stem Cells/metabolism , Stem Cells/pathology
5.
Cell Rep ; 26(4): 906-920.e3, 2019 01 22.
Article in English | MEDLINE | ID: mdl-30673613

ABSTRACT

The spread of mosquito-borne Zika virus (ZIKV), which causes neurological disorders and microcephaly, highlights the need for countermeasures against sudden viral epidemics. Here, we tested the concept that drugs targeting host proteostasis provide effective antivirals. We show that different cytosolic Hsp70 isoforms are recruited to ZIKV-induced compartments and are required for virus replication at pre- and post-entry steps. Drugs targeting Hsp70 significantly reduce replication of different ZIKV strains in human and mosquito cells, including human neural stem cells and a placental trophoblast cell line, at doses without appreciable toxicity to the host cell. By targeting several ZIKV functions, including entry, establishment of active replication complexes, and capsid assembly, Hsp70 inhibitors are refractory to the emergence of drug-resistant virus. Importantly, these drugs protected mouse models from ZIKV infection, reducing viremia, mortality, and disease symptoms. Hsp70 inhibitors are thus attractive candidates for ZIKV therapeutics with the added benefit of a broad spectrum of action.


Subject(s)
Antiviral Agents/pharmacology , HSP70 Heat-Shock Proteins/antagonists & inhibitors , Neural Stem Cells , Virus Internalization/drug effects , Virus Replication/drug effects , Zika Virus Infection , Zika Virus/physiology , Animals , Cell Line, Tumor , Disease Models, Animal , HSP70 Heat-Shock Proteins/metabolism , Humans , Mice , Mice, Knockout , Microcephaly/drug therapy , Microcephaly/metabolism , Microcephaly/pathology , Microcephaly/virology , Neural Stem Cells/metabolism , Neural Stem Cells/pathology , Neural Stem Cells/virology , Zika Virus Infection/drug therapy , Zika Virus Infection/metabolism , Zika Virus Infection/pathology
6.
Int Rev Cell Mol Biol ; 340: 79-128, 2018.
Article in English | MEDLINE | ID: mdl-30072094

ABSTRACT

Proteases are localized throughout mitochondria and function as critical regulators of all aspects of mitochondrial biology. As such, the activities of these proteases are sensitively regulated through transcriptional and post-translational mechanisms to adapt mitochondrial function to specific cellular demands. Here, we discuss the stress-responsive mechanisms responsible for regulating mitochondrial protease activity and the implications of this regulation on mitochondrial function. Furthermore, we describe how imbalances in the activity or regulation of mitochondrial proteases induced by genetic, environmental, or aging-related factors influence mitochondria in the context of disease. Understanding the molecular mechanisms by which cells regulate mitochondrial function through alterations in protease activity provide insights into the contributions of these proteases in pathologic mitochondrial dysfunction and reveals new therapeutic opportunities to ameliorate this dysfunction in the context of diverse classes of human disease.


Subject(s)
Mitochondria/enzymology , Peptide Hydrolases/metabolism , Stress, Physiological , Animals , Eukaryota/enzymology , Eukaryota/physiology , Humans , Mitochondria/physiology , Mitochondrial Proteins/metabolism
7.
Cell Rep ; 14(9): 2041-2049, 2016 Mar 08.
Article in English | MEDLINE | ID: mdl-26923599

ABSTRACT

The mitochondrial inner membrane proteases YME1L and OMA1 are critical regulators of essential mitochondrial functions, including inner membrane proteostasis maintenance and mitochondrial dynamics. Here, we show that YME1L and OMA1 are reciprocally degraded in response to distinct types of cellular stress. OMA1 is degraded through a YME1L-dependent mechanism in response to toxic insults that depolarize the mitochondrial membrane. Alternatively, insults that depolarize mitochondria and deplete cellular ATP stabilize active OMA1 and promote YME1L degradation. We show that the differential degradation of YME1L and OMA1 alters their proteolytic processing of the dynamin-like GTPase OPA1, a critical regulator of mitochondrial inner membrane morphology, which influences the recovery of tubular mitochondria following membrane-depolarization-induced fragmentation. Our results reveal the differential stress-induced degradation of YME1L and OMA1 as a mechanism for sensitively adapting mitochondrial inner membrane protease activity and function in response to distinct types of cellular insults.


Subject(s)
Metalloendopeptidases/metabolism , Mitochondria/enzymology , ATPases Associated with Diverse Cellular Activities , Adenosine Triphosphate/metabolism , Cell Line , Humans , Membrane Potential, Mitochondrial , Mitochondrial Proteins , Peptide Hydrolases/metabolism , Proteolysis
8.
EMBO Rep ; 16(1): 97-106, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25433032

ABSTRACT

Mitochondrial proteostasis is maintained by a network of ATP-dependent quality control proteases including the inner membrane protease YME1L. Here, we show that YME1L is a stress-sensitive mitochondrial protease that is rapidly degraded in response to acute oxidative stress. This degradation requires reductions in cellular ATP and involves the activity of the ATP-independent protease OMA1. Oxidative stress-dependent reductions in YME1L inhibit protective YME1L-dependent functions and increase cellular sensitivity to oxidative insult. Collectively, our results identify stress-induced YME1L degradation as a biologic process that attenuates protective regulation of mitochondrial proteostasis and promotes cellular death in response to oxidative stress.


Subject(s)
Metalloendopeptidases/metabolism , Mitochondria/metabolism , Oxidative Stress , ATPases Associated with Diverse Cellular Activities , Adenosine Triphosphate/metabolism , Cell Line , HEK293 Cells/drug effects , HEK293 Cells/metabolism , Humans , Hydrogen Peroxide/pharmacology , Intracellular Membranes/metabolism , Metalloendopeptidases/genetics , Mitochondrial Proteins/metabolism , Proteolysis
9.
Trends Endocrinol Metab ; 25(10): 528-37, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25048297

ABSTRACT

The endoplasmic reticulum (ER) and mitochondria form physical interactions involved in the regulation of biologic functions including mitochondrial bioenergetics and apoptotic signaling. To coordinate these functions during stress, cells must coregulate ER and mitochondria through stress-responsive signaling pathways such as the ER unfolded protein response (UPR). Although the UPR is traditionally viewed as a signaling pathway responsible for regulating ER proteostasis, it is becoming increasingly clear that the protein kinase RNA (PKR)-like endoplasmic reticulum kinase (PERK) signaling pathway within the UPR can also regulate mitochondria proteostasis and function in response to pathologic insults that induce ER stress. Here, we discuss the contributions of PERK in coordinating ER-mitochondrial activities and describe the mechanisms by which PERK adapts mitochondrial proteostasis and function in response to ER stress.


Subject(s)
Endoplasmic Reticulum Stress/physiology , Mitochondria/physiology , Protein Unfolding , Unfolded Protein Response/physiology , Animals , Humans , Signal Transduction/physiology
10.
Cell Metab ; 18(6): 908-19, 2013 Dec 03.
Article in English | MEDLINE | ID: mdl-24315374

ABSTRACT

Stress-regulated signaling pathways protect mitochondrial proteostasis and function from pathologic insults. Despite the importance of stress-regulated signaling pathways in mitochondrial proteome maintenance, the molecular mechanisms by which these pathways maintain mitochondrial proteostasis remain largely unknown. We identify Tim17A as a stress-regulated subunit of the translocase of the inner membrane 23 (TIM23) mitochondrial protein import complex. We show that Tim17A protein levels are decreased downstream of stress-regulated translational attenuation induced by eukaryotic initiation factor 2α (eIF2α) phosphorylation through a mechanism dependent on the mitochondrial protease YME1L. Furthermore, we demonstrate that decreasing Tim17A attenuates TIM23-dependent protein import, promotes the induction of mitochondrial unfolded protein response (UPR)-associated proteostasis genes, and confers stress resistance in C. elegans and mammalian cells. Thus, our results indicate that Tim17A degradation is a stress-responsive mechanism by which cells adapt mitochondrial protein import efficiency and promote mitochondrial proteostasis in response to the numerous pathologic insults that induce stress-regulated translation attenuation.


Subject(s)
Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Oxidative Stress , ATPases Associated with Diverse Cellular Activities , Animals , Arsenic/toxicity , Caenorhabditis elegans/metabolism , Cell Line , Eukaryotic Initiation Factor-2/metabolism , HEK293 Cells , HeLa Cells , Humans , Metalloendopeptidases/antagonists & inhibitors , Metalloendopeptidases/genetics , Metalloendopeptidases/metabolism , Mice , Mitochondria/drug effects , Mitochondrial Membrane Transport Proteins/antagonists & inhibitors , Mitochondrial Membrane Transport Proteins/genetics , Mitochondrial Precursor Protein Import Complex Proteins , Mitochondrial Proteins , Oxidative Stress/drug effects , Paraquat/toxicity , Phosphorylation , Protein Biosynthesis/drug effects , Protein Transport/drug effects , Unfolded Protein Response/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...